Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_assertion type Assertion NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_head.
- NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_assertion description "[The purpose of this study was to evaluate associations between germline epidermal growth factor receptor (EGFR) variants involved in transcriptional regulation and overall survival in white patients with non-small-cell lung cancer (NSCLC) treated with the EGFR tyrosine kinase inhibitor, gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_provenance.
- NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_assertion evidence source_evidence_literature NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_provenance.
- NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_assertion SIO_000772 17713473 NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_provenance.
- NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_assertion wasDerivedFrom befree-2016 NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_provenance.
- NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_assertion wasGeneratedBy ECO_0000203 NP626285.RAQ81HhgBWwyUc0ncL6yp_olB5vNy_75BLpYfdO8N6yCc130_provenance.